The course of type 1 hepato-renal syndrome post liver transplantation

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 478-482

  Marik, Paul E ^a,b   Wood, Kelly ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cirrhosis; Dialysis; Hepato renal syndrome; Liver transplantation; Renal failure

Indexed keywords

ALEMTUZUMAB; BILIRUBIN; CREATININE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACCURACY; ADULT; AGE; ALCOHOL LIVER DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIALYSIS; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HEPATORENAL SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVER TRANSPLANTATION; MALE; MORTALITY; ORTHOTOPIC TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM;

FEMALE; HEPATORENAL SYNDROME; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 31544469480     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi212     Document Type: Review

References (32)

1. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-365
2. Lafayette RA, Pare G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997; 48: 159-164
3. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003; 362: 1819-1827
4. Gines A, Escorsell A, Gines P et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-236
5. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157
6. Cassinello C, Moreno E, Gozalo A, Ortuno B, Cuenca B, Solis-Herruzo JA. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci 2003; 48: 179-186
7. Arroyo V, Gines P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23: 164-176
8. Moreau R. Hepatorenal syndrome in patients with cirrhosis. J Gastroenterol Hepatol 2002; 17: 739-747
9. Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: Diagnostic accuracy, clinical features and outcome in a tertiary care center. Am J Gastroenterol 2002; 97: 2046-2050
10. Angeli P. Review article: Prognosis of hepatorenal syndrome - has it changed with current practice? Alimentary Pharmacology & Therapeutics 2004; 20 [Suppl 3]: 44-46
11. Cardenas A, Arroyo V. Hepatorenal syndrome. Ann Hepatol 2003; 2: 23-29
12. Saner FH, Fruhauf NR, Schafers RF, Lang H, Malago M, Broelsch CE. Terlipressin plus hydroxyethyl starch infusion: An effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol 2003; 15: 925-927
13. Duvoux C, Zanditenas D, Hezode C et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study. Hepatology 2002; 36: 374-380
14. Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003; 18: 152-156
15. Moreau R, Durand F, Poynard T et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study. Gastroenterology 2002; 122: 923-930
16. Catalano G, Urbani L, Biancofiore G et al. Selection and preparation of candidates for combined liver-kidney transplantation: Experience at a single center-two case reports. Transplantat Proc 2004; 36: 539-540
17. Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96
18. Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874
19. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 1991; 51: 428-430
20. Iwatsuki S, Popovtzer MM, Corman JL et al. Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med 1973; 289: 1155-1159
21. Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Renal Failure 2004; 26: 563-568
22. Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003; 139: 186-193
23. Mookerjee RP, Sen S, Davies NA, Hodges SJ, Williams R, Jalan R. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 2003; 52: 1182-1187
24. Iglesias J, Marik PE, Levine JS, Norasept IS, I. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis 2003; 41: 62-75
25. Anggard E, Jones AW, Neri A. Effect of acute and chronic ethanol treatment on renal prostaglandins in the rat. Alcohol 1985; 2: 647-650
26. Vamvakas S, Teschner M, Bahner U, Heidland A. Alcohol abuse: Potential role in electrolyte disturbances and kidney diseases. Clin Nephrol 1998; 49: 205-213
27. Van Thiel DH, Gavaler JS, Little JM, Lester R. Alcohol: Its effect on the kidney. Adv Exp Med Biol 1977; 85A: 449-457
28. Van Thiel DH, Williams WD Jr., Gavaler JS, Little JM, Estes LW, Rabin BS. Ethanol-its nephrotoxic effect in the rat. Am J Pathol 1977; 89: 67-83
29. Jeyarajah DR, Gonwa TA, McBride M et al. Hepatorenal syndrome: Combined liver kidney transplants versus isolated liver transplant. Transplantation 1997; 64: 1760-1765
30. Margreiter R, Konigsrainer A, Spechtenhauser B et al. Our experience with combined liver-kidney transplantation: An update. Transplant Proc 2002; 34: 2491-2492
31. Jeyarajah DR, McBride M, Klintmalm GB, Gonwa TA. Combined liver-kidney transplantation: What are the indications? Transplantation 1997; 64: 1091-1096
32. Restuccia T, Ortega R, Guevara M et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 2004; 40: 140-146